Qunatra Qplus System
Device Hematology
PDI 00850003761039
General payments
$186,578
Research payments
$1,875,888
Through program year 2025, $186,578 in general payments and $1,875,888 in research payments were reported against Qunatra Qplus System (Hematology).
No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.
By program year
6 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2025 | General | $45,417 | 308 |
| 2025 | Research | $1,265,569 | 84 |
| 2024 | General | $100,734 | 219 |
| 2024 | Research | $235,880 | 18 |
| 2022 | General | $40,427 | 284 |
| 2022 | Research | $374,439 | 27 |
Breakdown
The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2025.
The top 5 of 31 specialties; each share is of general payments naming this product to practitioners with a specialty in 2025. Each practitioner is counted under their primary specialty.
The top 5 of 28 states; each share is of general payments naming this product in 2025 where a state was reported.
Records
811 general · 129 researchEvery payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
What you are looking at
Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.